Inpatient Detoxification Procedure and Facilities: Financing Considerations from an Eastern European Perspective

Jovanovic, Mirjana; Jakovljević, Mihajlo

doi:10.1093/alcalc/agr010

Cited by 20 publications

(21 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Size of mental disorder related costs of care seems to be just disorder related costs of care seems to be just slightly lower in Serbia compared to Central slightly lower in Serbia compared to Central European values [39,40]. Structure of costs inEuropean values [39,40]. Structure of costs indicates direct costs are prevailing against indidicates direct costs are prevailing against indirect cost contribution.…”

Section: Discussionmentioning

confidence: 96%

See 1 more Smart Citation

Cost-effectiveness of depressive episode pharmacological treatment

Jakovljević¹,

Yamada²,

Ching³

et al. 2015

Hosp Pharm Int Multi J

View full text Add to dashboard Cite

SUMMARY Background and ObjectivesThere is a paucity of published cost-eff ectiveness studies of alternative scenarios in depressive episode acute medical care in Eastern European populations. Methods Prospective cost-eff ectiveness analysis was conducted on 65 depressive patients in a large university clinic [May 2010-February 2012. Patient visits to attending psychiatrists were scheduled at baseline, 3rd and 8th week. HDRS-17 was deployed to assess clinical effi ciency and Q-LES-Q-SF scale for life quality assessment. Resource use and costs were evidenced from the Clinic's electronic registry of discharge invoices [national currency 1 €≈115.

show abstract

Section: Discussionmentioning

confidence: 96%

“…Size of mental cal outcomes assessment [38]. Size of mental disorder related costs of care seems to be just disorder related costs of care seems to be just slightly lower in Serbia compared to Central slightly lower in Serbia compared to Central European values [39,40]. Structure of costs inEuropean values [39,40].…”

Section: Discussionmentioning

confidence: 99%

Cost-effectiveness of depressive episode pharmacological treatment

Jakovljević¹,

Yamada²,

Ching³

et al. 2015

Hosp Pharm Int Multi J

View full text Add to dashboard Cite

show abstract

“…Највећа разлика у хоспиталним трошковима огледа се код конзумената/неконзумената алкохола и дувана; за балканске земље, укључујући и нашу, познато је да имају високу стопу злоупотребе и зависности од алкохола (21).…”

Section: табела 3 структура трошкова у зависности од фактора ризикаunclassified

The costs of heart failure treatment and the influence of risk factors

Zdravković¹

2013

Medicinski casopis

View full text Add to dashboard Cite

УВОДАнализа трошкова одређених обољења била је једна од првих економских анализа која се користила у области здравства (1). Она има за циљ да процени колики економски терет представља болест за становништво у целини (2, 3). Врши се на основу увида у директне и индиректне трошкове, односно трошкове превенције, откривања, лечења и одсуства са радног места, смањења радне способности, превременог смртног исхода (4, 5).Данас је срчана инсуфицијенција не само проблем за појединца већ и за друштво у целини и економију саме државе (6). Она представља недовољну способност срца да пумпа адекватну количину крви за потребе органа и ткива, у миру и напору, којом би се задовољиле метаболичке потребе организма и поред нормалног прилива крви у леву и десну комору. Срчана инсуфицијенција није примарно само болест срца већ целог организма, и има три механизма за компензовање недовољног минутног волумена и конгестије (дилатација срца, хипертрофија и повећање контрактилности миокарда и фреквенције срчаног 24.036,82 (од 9.592,83 до 212.718,97), за медикаментозно лечење 13.709,06 (од 3.251,4 до 68.740,20) и за амбулантне услуге 8.929,68 (од 2.056,24 до 19.968,93), док је збир свих трошкова износио 46.675,06 (од 11.565,89 до 244.612,89 24,036.82 (9,592.83 to 212,718.97), for drug treatment 13,709.06 (3,251.40 to 68,740.20), for ambulatory services 8,929.68 (2,056.24 to 19,968.93) while the total costs were 46,675.06 (11,565.89 to 244,612.89 (62,298.38).Conclusions. Hospital costs represented the majority of treatment costs of patients with heart failure. Costs of treating heart failure in patients with risk factors (smoking, obesity, alcoholism, diabetes, and hypertension) were 1.76 times higher.

show abstract

“…Some of these cost evaluations in clinical settings have examined patients suffering from diabetes mellitus type 2, chronic obstructive pulmonary disease, alcohol addiction, rheumatoid arthritis, haemodialysis, preterm labour management and other medical conditions that have the most significant budgetary impact in the domestic health care setting (2)(3)(4)(5). Some of these analyses were designed as classical cost of illness analyses, others were designed as comparative economic evaluations (cost/utility and cost/effectiveness trials) and the remaining analyses used an in-depth modelling approach with TreeAge commercial software.…”

Section: Searching For Local Evidence  Domestic Research Efforts In mentioning

confidence: 99%